No clot, just clout: Trump's bruises from ‘frequent handshaking', says White House
No signs of serious health issues, Trump's doctor confirms
WASHINGTON, July 18 — The White House said on Thursday that US President Donald Trump is experiencing swelling in his lower legs and bruising on his right hand, after photographs emerged of Trump with swollen ankles and makeup covering the afflicted part of his hand.
White House spokeswoman Karoline Leavitt, reading a letter from Trump's doctor at a press briefing, said both ailments were benign. His leg swelling is from a 'common' vein condition, and his hand is bruised from shaking so many hands, she told reporters.
The disclosure sought to put to rest a raft of internet rumors that the 79-year-old Trump might be suffering from a serious ailment based on the photographic evidence.
After Leavitt's briefing, the White House released the letter from a US Navy officer who is Trump's physician, Sean Barbabella. It said Trump underwent a suite of tests about the issues.
Barbabella said an ultrasound on the president's legs 'revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70.'
The letter said there was no evidence Trump had contracted deep vein thrombosis or arterial disease.
Additional exams identified no signs of heart failure, kidney impairment, or a systemic illness, Barbabella said.
Leavitt told reporters Trump was not experiencing discomfort due to the condition.
Barbabella also said that Trump had bruising on the back of his right hand.
He described this as 'consistent with minor soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen.'
'President Trump remains in excellent health,' he said.
Kwame Amankwah, a physician who is chief of vascular surgery at the University of Connecticut in Hartford, said chronic venous insufficiency is usually an issue with the lower legs in which the veins have problems sending blood from the legs back to the heart.
It is usually treated with compression stockings and leg elevation, he said.
'Even if he doesn't have heart disease, the condition needs to be addressed. If it's not managed with compression stockings and elevation, severe swelling and ulcers can develop, warranting more significant medical interventions,' Amankwah said.
Todd Berland, a physician who is director of outpatient vascular interventions at NYU Langone Health, said chronic venous insufficiency 'has no overall effect on life expectancy. It's a quality-of-life issue, not a quantity of life issue.'
Trump underwent an extensive physical examination on April 11 at Walter Reed National Military Medical Center in suburban Washington. It said Trump had a normal heart rhythm and no major health problems. — Reuters
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
an hour ago
- Malay Mail
IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem
HONG KONG SAR - Media OutReach Newswire - 21 July 2025 – IVD Medical Holding Limited( - Forward-looking layout of the historical opportunity of the US "Genius Act", the IVDD stablecoin plan is gathering momentum to set sail and build a new global infrastructure for medical innovative drugs RWA!In the wave of deep integration of global digital finance and medical innovation, IVD Medical Holding Limited( took the lead in building the "NewCo+RWA" Web3 exchange ecosystem (IVDNewCo Exchange) with the construction of medical innovative drugs high-tech assets as the core and the supporting stablecoin "IVDDollar" (IVDD) plan as the core strategy, leading the digital revolution of global medical innovation July 20, 2025, the Board of Directors is pleased to announce that the US subsidiary carrying the Group's aforementioned core strategic mission has landed, and the IVDNewCo Exchange ecosystem has officially landed on the international financial stage. The company released the latest announcement today, officially announcing two milestones: the US wholly-owned subsidiary IVD GROUP INC. has completed registration, and the Group has officially started the process of submitting a stablecoin license application to the US regulator through the subsidiary; at the same time, the Web3 exchange ecosystem with medical innovative drug NewCo assets as the core - IVDNewCo Exchange and its supporting stablecoin IVDD have entered a substantive strategic move not only marks the Group's leading position in the field of compliant digital finance for medical innovative drugs, but also heralds a revolutionary breakthrough in the global medical asset liquidity and value conversion July 18, 2025, local time, US President Trump signed the "Guidance and Establishment of the United States Stablecoin National Innovation Act" (hereinafter referred to as the "Genius Act") at the White House, establishing the legal status of stablecoins as "digital dollars". The implementation of this bill, together with the Stablecoin Ordinance of the Hong Kong Special Administrative Region, which will take effect on August 1, forms a regulatory synergy between the East and the West, and jointly builds the compliance cornerstone of the global stablecoin report of the China Banking Research Institute pointed out that currently 99% of the world's stablecoins are anchored to US dollar assets, and US Treasury bonds have become the core choice of stablecoin reserve assets due to their low risk and high liquidity. In this context, the Group proactively laid out the application for the US stablecoin license, and on July 20 officially announced that the US subsidiary had initiated the process of submitting application materials to regulatory agencies such as the US SEC and CFTC, becoming one of the very few listed companies in the Hong Kong stock market that has completed the "Hong Kong + US" dual hub compliance architecture strategic layout of the Group is deeply in line with the global regulatory trend. By establishing the US subsidiary IVD GROUP INC., we not only meet the strict requirements of the "Genius Act" for 100% reserve asset coverage and independent auditing of stablecoin issuers, but also rely on the sandbox mechanism of the Hong Kong "Stablecoin Ordinance" to build a cross-regional regulatory endorsement system. This dual hub model provides the IVDNewCo Exchange ecosystem with globally rare compliant liquidity support, enabling the Group to establish a first-mover advantage in the "Hong Kong Stock Stablecoin Concept Sector".The core breakthrough of the IVDNewCo Exchange ecosystem lies in the deep integration of Web3 technology and medical innovative drug assets. Relying on the commercial network covering 1,674 tertiary hospitals in China and the ability to acquire high-quality NewCo assets around the world, the Group has created the world's first RWA (real world asset) tokenization platform focusing on medical innovative drugs. The platform achieves the following innovations through blockchain technology:1). Asset tokenization: converting innovative drug assets such as ADC drugs, bi-antibody therapy, and cell gene therapy in the clinical stage into tradable and divisible digital certificates to break through the liquidity bottleneck of traditional medical assets;2). Compliance financial infrastructure: establish an underlying architecture to support the issuance, trading and settlement of IVDD stablecoins, ensuring that each $1 stablecoin corresponds to ultra-short-term U.S. Treasury bonds and other low-risk assets, meeting the U.S. SEC's "1:1 redeemable" requirements;3). Coin-stock linkage mechanism: coordinate with Nasdaq's dual primary listing plan to explore the compound value creation model of "digital assets + traditional equity" to attract two-way inflows of traditional medical capital and crypto-native implementation of this technical architecture has been strongly supported by industry data. Public information shows that the current global innovative drug market has exceeded US$1.2 trillion, and China accounts for 6% of the market with a scale of RMB 450 billion, with an annual compound growth rate of 20.3%. Through the RWA platform, the Group expects to significantly improve the financing efficiency of innovative drug assets, while lowering the entry threshold for investors, allowing small and medium-sized investors around the world to participate in the medical innovation field that was originally limited to institutional Group's strategic advancement has always followed the three-dimensional path of "regulatory compliance-technological innovation-ecological synergy". In the United States, IVD GROUP INC.'s license application strictly follows the requirements of the Genius Act for reserve asset transparency, anti-money laundering (AML) and network security. Its technical system has passed a third-party security audit to ensure that smart contracts are free of loopholes; in Hong Kong, the Group will actively promote participation in the HKMA's stablecoin sandbox program to test reserve asset management and cross-border payment scenarios, laying the foundation for license importantly, the implementation of the IVDNewCo Exchange ecosystem is reshaping the value chain of innovative medical drugs. Under the traditional model, the research and development of innovative drugs requires a cycle of up to 10 years, and 80% of the funds are concentrated in the clinical stage. Through the RWA platform, the Group can monetize clinical-stage assets in advance, provide pharmaceutical companies with low-cost financing channels, and provide investors with dynamic returns linked to the progress of drug development. For example, an ADC drug in Phase II clinical trials can attract global capital participation through tokenization, and its development progress data will be uploaded to the chain in real time to ensure that investors' rights and interests are transparent and Group's strategic initiatives have attracted widespread attention from the capital market and the industry. After the announcement on the 17th, IVD Medical's share price opened sharply higher on the 18th, closing at HK$2.95, up 20.41% throughout the day, with a turnover exceeding HK$9.4886 million and a market value of HK$4.783 billion. Behind the market data is investors' strong confidence in the cross-border integration of "NewCo+RWA+stablecoin".Looking ahead, the Group will continue to deepen the three strategic directions of compliance expansion, technology deepening and ecological integration. Against the backdrop of the global low interest rate environment and the surge in demand for medical innovation, it will use Web3 technology as a bridge to connect traditional medical capital and digital financial innovation. We firmly believe that through compliance layout and technological innovation, the IVDNewCo Exchange ecosystem will become a value amplifier for global innovative medical drug assets, creating a win-win situation for patients, pharmaceutical companies and #IVDMedicalHoldingLimited The issuer is solely responsible for the content of this announcement.
The Sun
2 days ago
- The Sun
US rejects WHO pandemic reforms under Trump administration
WASHINGTON: The United States has formally rejected amendments to the World Health Organization's pandemic response framework, with the Trump administration arguing the changes infringe on national sovereignty. Secretary of State Marco Rubio and Health Secretary Robert F. Kennedy Jr announced the decision, stating the reforms risk undue interference in US health policy. 'We will put Americans first in all our actions and we will not tolerate international policies that infringe on Americans' speech, privacy or personal liberties,' Rubio and Kennedy said in a joint statement. The rejected amendments, agreed upon at the 2024 World Health Assembly, aimed to strengthen global disease response mechanisms, including provisions for equity in health emergencies. WHO Director-General Tedros Adhanom Ghebreyesus expressed disappointment, stating the amendments 'are clear about member states sovereignty' and do not mandate lockdowns. The reforms included a commitment to study developing nations' needs during health crises. Conservative groups in Britain and Australia have also opposed the changes, fearing overreach. The US had already begun withdrawing from the WHO earlier this year, following Trump's return to office. The Biden administration had participated in 2024 negotiations but refused consensus over intellectual property concerns. Rubio and Kennedy criticized the WHO for alleged susceptibility to political influence, particularly from China. Tedros defended the organization as impartial, working 'with all countries to improve people's health.' - AFP
Malay Mail
2 days ago
- Malay Mail
Fatal pull: MRI machine claims life of man wearing metal necklace in New York
NEW YORK, July 19 — A 61-year-old man has died after being pulled into an MRI machine by his chain necklace at a diagnostic imaging centre in Westbury, New York, authorities said. The fatal incident occurred on Wednesday at Nassau Open MRI and is under investigation. According to a statement by the Nassau County Police Department cited by The New York Times, the man entered the MRI room at 4.34pm local time wearing a 'large metallic chain' around his neck. He did not have authorisation to be in the room, police said. The magnetic force of the machine pulled the man toward it, triggering what authorities described as a 'medical episode'. He was transported to a nearby hospital but died the following afternoon at 2.36pm. Police have not released the man's name. A spokesman said yesterday that the investigation is ongoing and that no additional information was currently available. Nassau Open MRI did not respond to requests for comment. Magnetic resonance imaging (MRI) machines use powerful magnets and radio waves to generate detailed images of internal organs and tissues. The machines' strong magnetic fields can be dangerous if metallic objects are brought into the room, with the National Institute of Biomedical Imaging and Bioengineering noting that items as large as wheelchairs can become projectiles. Patients and staff are typically required to remove all metal objects before entering an MRI room. People with certain medical implants may be advised against undergoing scans. Serious incidents involving MRI machines are rare but have occurred before. In 2001, a six-year-old boy in New York was killed when a metal oxygen tank was pulled into the machine during a scan. In 2018, a man in India carrying an oxygen tank died after entering an MRI room. Most recently in 2023, a nurse in California was crushed and injured when an MRI machine's magnetic pull dragged a hospital bed into her. Nassau Open MRI offers both closed and open MRI scans, with the latter designed to be more accessible for patients who experience claustrophobia.
